Clinical Trials

Clinical TrialsAdvanced Pain Management is at the forefront in developing the pain treatments of the future. We conduct next-generation clinical trials and engage in research that has the potential to produce dramatic improvements in patient outcomes.

Current Clinical Trials


Halyard Health- Genicular Radiofrequency Study

This study is designed to:

  • Determine the effectiveness (primarily measured by pain relief) of Coolief when used to create radiofrequency lesions of the genicular nerves compared to pain relief following corticosteroid injection; and
  • Confirm the safety of Coolief when used to perform radiofrequency lesions of the genicular nerves in subjects to manage knee pain compared to safety of corticosteroid injection

Nevro Chronic Pelvic Pain Pilot Study

This is a pilot study designed to determine the efficacy of spinal cord stimulation to relieve chronic pelvic pain secondary to diagnosis’ such as but not limited to pudendal neuralgia, endometriosis, pain related to pregnancy complications, post pelvis surgery pain, trauma, erectile dysfunction and etc.


Nevro Diabetic Neuropathy Study

This post-market study is being conducted to document comparative safety, clinical effectiveness, and cost-effectiveness of the addition of HF10™ therapy to CMM compared with CMM alone in subjects with chronic, intractable, neuropathic lower limb pain due to diabetic neuropathy (Painful Diabetic Neuropathy or PDN). This study is a multi-center, prospective, randomized comparison of the two treatments.


St Jude Medical Post Market – TARGET Study

The purpose of this prospective, multicenter, single arm post-approval study is to demonstrate continued safety of the Axium Neurostimulator System for dorsal root ganglion (DRG) stimulation. The primary endpoint is the 12-month serious adverse event rate for permanent implants.


St Jude Medical Post Market TRIUMPH Study

The purpose of this prospective, multicenter, single arm post-approval study is to demonstrate continued safety of the Axium Neurostimulator System  spinal cord stimulation. The primary endpoint is the 12-month serious adverse event rate for permanent implants.


Boston Scientific Post Market RELIEF Registry

The purpose of this study is to compile characteristics of real-world clinical outcomes for Boston Scientific commercially approved neurostimulation systems for pain in routine clinical practice, when used according to the applicable Directions for Use and to evaluate the economic value and technical performance of Boston Scientific commercially approved neurostimulation systems for pain in routine clinical practice


Boston Scientific Investigator Initiated Opioid Reduction Study

The primary objective of this study is to assess the efficacy of spinal cord stimulation in the reduction of opioids post implant.    


Saluda

A prospective, multicenter, randomized, double-blind study examining the safety and efficacy of using the Evoke™ Spinal Cord Stimulator (SCS) System with feedback to treat patients with chronic pain of the trunk and/or limbs.


Semnur Epidural Steroid Study (C L E A R Corticosteroid Lumbar Epidural Analgesia For Radiculopathy)

A prospective, multicenter randomized, double blind study examining the safety and efficacy of using dexamethasone sodium phosphate viscous gel solution versus placebo for the treatment of radiculopathy.

 

* Some pre-screening clinic fees may apply to the clinical trial

For additional information contact our research coordinator at
research@apmhealth.com or (414) 325-3724